The COVID-19 vaccine has prompted more than 10 times as many reports of adverse symptoms than the measles vaccine.

Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...

House Republicans are urging President Trump to use executive action on COVID-19 mandates for organ transplants.

Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...

Complacency worries public health officials, who fear that a mutation or another virus could be worse than COVID, which ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...

The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...

The new vaccine addresses significant limitations of existing COVID-19 and flu vaccines. While mRNA COVID-19 vaccines require ...

A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...

Children vaccinated against COVID-19 were more than 50% less likely to develop at least one long COVID symptom compared with ...

Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...